Pharmaceutical form | Stanozolol 10 mg Tablets. There are 25 tablets in a blister. 4 blisters are packed in a cardboard box together with an enclosed leaflet. |
Active ingredient | Stanozolol 10 mg |
Pharmacotherapeutic group | Anabolic / androgenic steroids. |
Stanozolol is used for general worsening of the condition during aplastic anemia, anorexia, during the recovery period after a chronic illness, surgery, burns and fractures, for tissue repair, debilitating diseases, postmenopausal or elderly osteoporosis, protein metabolism disorders with loss of muscle mass and negative nitrogen balance. It is also used for nephrotic syndromes, asthma. It helps to get rid of the catabolic effect of corticosteroids, and also as an adjuvant in the treatment of pressure ulcers, osteoporosis. Preventive treatment for hereditary angioedema by increasing protein synthesis. In pediatrics, it is used to treat stunting and underweight, dystrophies, and immaturity. |
Package leaflet (information for patients)
Tradename
Stanozolol
Dosage form
Tablets 10 mg.
Description
Round, flat, beveled to the edge white tablets with an imprint in the form of the brand name "V" on one side.
Composition
Active ingredient: Stanozolol 10 mg.
Excipients: microcrystalline cellulose 102, calcium stearate, aerosil ® 200 (hydrophilic pyrogenic silicon dioxide).
Pharma co-therapeutic group
Anabolic / androgenic steroids.
Pharmacological properties
Anabolic steroids correct corticosteroid catabolism and reverse the deep negative nitrogen balance that occurs with corticosteroid therapy. Mechanism of action: in debilitated patients, anabolic steroids stimulate cellular protein synthesis. (If the nitrogen balance is positive, then anabolism occurs.) They also induce feelings of well-being in debilitated patients, encouraging them to eat more and gain weight. Improves calcium balance and reduces bone resorption.
Indications for use
Stanozolol is used for general worsening of the condition during aplastic anemia, anorexia, during the recovery period after a chronic illness, surgery, burns and fractures, for tissue repair, debilitating diseases, postmenopausal or elderly osteoporosis, protein metabolism disorders with loss of muscle mass and negative nitrogen balance. It is also used for nephrotic syndromes, asthma. It helps to get rid of the catabolic effect of corticosteroids, and also as an adjuvant in the treatment of pressure ulcers, osteoporosis. Preventive treatment for hereditary angioedema by increasing protein synthesis
In pediatrics, it is used to treat stunting and underweight, dystrophies, and immaturity.
Method of administration and dosage
Film-coated tablets should be swallowed whole with plenty of water. The drug should not be taken on an empty stomach.
After surgery, burns and fractures, for tissue repair, debilitating diseases : Adults: Initially, 10 mg orally per day. Supportive care: 2.5 to 5 mg daily.
A nabolic effect: Adults: 10–20 mg orally per day.
Severe depletion: Adults: 10-20 mg orally daily for 3 weeks. Thereafter, reduce to 5-10 mg per day for maintenance.
Side effects
If you get any side effects, see your doctor. These include any possible side effects not listed in this leaflet.
Androgenic Effects : In women, acne, edema, oily skin, weight gain, hirsutism, hoarseness, clitoral growth, changes in libido. In prepubertal men; premature closure of the pineal gland, acne, priapism, hair growth on the face and body, phallic growth; post - pubertal period: testicular atrophy, oligospermia, decreased ejaculation volume, impotence, gynecomastia, epididymitis. Swelling, burning sensation in the tongue, gastroenteritis, nausea, vomiting, changes in appetite, diarrhea, anorexia, constipation, irritability of the bladder, jaundice may also occur.
Hypoestrogenic effects : in women, hot flashes or redness; sweating; dry, itchy, burning, or bleeding vaginitis; menstrual irregularities. Hypercalcemia, electrolyte imbalance: sodium, chloride, water, potassium and calcium retention may also occur; decreased glucose tolerance.
Contraindication
- contraindicated in case of hypersensitivity to stanozolol
- prostate carcinoma
- hormone-dependent tumors in men
- active hypercalcemia and liver failure.
- in the presence of prostate cancer
- breast cancer in men
- heart failure
- hepatic or renal decompensation
- nephrosis
- during pregnancy and lactation
It should be used with caution in children before puberty, in patients with diabetes or coronary artery disease, in people taking ACTH, corticosteroids, or anticoagulants.
Overdose
Symptoms: hepatotoxicity and intoxication. During intoxication, sweating, nausea, and vomiting may occur. These symptoms can be eliminated by reducing the dose.
Treatment: in case of signs of poisoning, induce vomiting or gastric lavage, prescribe activated charcoal and a laxative, and consult a doctor.
Intoxication and hepatotoxicity are more likely in elderly patients and especially in young children (therapeutic overdose or accidental intoxication can be very dangerous for them).
Precautions
- In patients with liver disease, it is advisable to monitor cholestasis.
- Patients sensitive to endocrine side effects should be observed periodically by a doctor during long-term treatment.
- In addition, stanozolol should be used with caution and under strict medical supervision in patients with heart failure, high blood pressure, epilepsy, migraine, diabetes mellitus, bone metastases, coagulation disorders.
- Pregnancy: May cause virilization in female fetuses.
- Breastfeeding: It is not known how anabolic steroids are excreted in breast milk. In accordance with the adverse reactions that may occur in infants, it is necessary to decide whether to stop breastfeeding or stop taking the drug.
- Pediatrics: The use of anabolic steroids can have serious consequences, the benefits of which should be assessed before starting therapy. Anabolic steroids can accelerate the maturation of the pineal gland in children faster than linear growth, and the effect can last up to 6 months after the drug is stopped. In any case, therapy should be monitored by X-ray studies at intervals of 3 to 6 months, and the drug should be discontinued before bone age reaches the norm for chronological age, in order to avoid the risk of deterioration in adult growth.
- Hepatotoxicity : including jaundice with or without itching. This may be associated with acute hepatitis, accompanied by pain in the right upper quadrant. The incidence of hepatocellular carcinoma has been observed with long-term treatment with high doses of androgens.
- Geriatrics: Geriatric patients taking anabolic steroids may have an increased risk of developing prostate hypertrophy and prostate carcinoma. This may be associated with acute hepatitis, accompanied by pain in the right upper quadrant. The incidence of hepatocellular carcinoma has been observed with long-term treatment with high doses of androgens.
Interaction with other medicinal products
Anabolic steroids can enhance the effect of oral anticoagulants: the dosage can be reduced to maintain prothrombin time. In diabetics, taking anabolic steroids may increase the need for insulin and oral hypoglycemic agents. Adrenocorticoids or ACTH can increase edema when used in combination with anabolic steroids. Methandienone lowers fasting blood glucose levels in both normal people and people with diabetes.
Special instructions
Peliosis of hepatitis can occur in patients receiving anabolic steroids. These cysts can be present with minimal liver dysfunction, but they are associated with a liver defect. Symptoms are often not recognized until a life-threatening liver problem or intra-abdominal bleeding develops. Discontinuation of anabolic steroid treatment usually results in complete resolution of the lesions. Tumors in liver cells have also been reported. Many of these tumors are benign and estrogen-dependent, but fatal malignant tumors have also been reported; discontinuation of the drug may lead to regression or cessation of tumor development. Even though androgen-related or anabolic steroid-associated liver tumors, they are much more vascular than other liver tumors and may not manifest until life-threatening intra-abdominal hemorrhage develops. Changes in blood lipids associated with an increased risk of arteriosclerosis in patients taking androgens and anabolic steroids. These changes include a decrease in high density lipoprotein changes and sometimes an increase in low density lipoprotein. The changes can be very noticeable and should seriously affect the risk of changes in blood lipids associated with an increased risk of arteriosclerosis in patients taking androgens and anabolic steroids
Pregnancy and elbowing
This drug should not be used during pregnancy and lactation.
During pregnancy, the drug can cause virilization in female fetuses.
During breastfeeding, it is not known how anabolic steroids are excreted in breast milk. In accordance with the adverse reactions that may occur in infants, it is necessary to decide whether to stop breastfeeding or stop taking the drug.
Influence on the ability to drive vehicles and work with mechanisms
Does not affect
Storage conditions
Store in a dry, dark place at a temperature not exceeding 25 °C, out of the reach of children.
Shelf life
3 years. Do not use after the expiration date printed on the package.
Vacation conditions
On prescription.
Packaging
Stanozolol 10 mg Tablets. There are 25 tablets in a blister. 4 blisters are packed in a cardboard box together with an enclosed leaflet.